Clinical Trials for Madrigal Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Madrigal Pharmaceuticals

Clinical Trials (3)

NCT05500222
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
PHASE3Active, not recruiting
700 participants
Started: Aug 26, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor55 locations
NCT04951219
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
PHASE3Active, not recruiting
1,000 participants
Started: Jul 9, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor71 locations
NCT03900429
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
PHASE3Active, not recruiting
1,759 participants
Started: Mar 28, 2019 · Completed: Jan 31, 2028
1 condition1 sponsor246 locations